Clinical Trial

H. Pylori Infection and AIP Levels

Study acronym: HP-AIP
Completed
View on ClinicalTrials.gov →
Summary
Helicobacter pylori is a common bacterial infection of the stomach that can cause ulcers and other digestive problems. Recent studies suggest that this infection may also affect metabolism and blood fats (lipids), which are important for heart health. Changes in lipid levels, such as higher triglycerides and lower "good" cholesterol (HDL), can increase the risk of cardiovascular disease. This study will examine whether H. pylori infection is linked to changes in lipid profiles, especially the Atherogenic Index of Plasma (AIP). AIP is a calculation based on triglycerides and HDL cholesterol that helps predict the risk of heart disease.
Trial Details
NCT Number NCT07306377
Lead Sponsor Tanta University
Conditions H Pylori Infection, Atherogenic Plasma Index
Enrollment 300 participants
Start Date 2025-01-02
Primary Completion 2025-02-18 (estimated)
Study Completion 2025-08-04 (estimated)
Updated on ClinicalTrials.gov 2025-12-29